{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:59:04Z","timestamp":1793411944393,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T00:00:00Z","timestamp":1716768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T00:00:00Z","timestamp":1716768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005774","name":"Universitat de Barcelona","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005774","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Aims<\/jats:title>\n                <jats:p>To determine the presence of sectoral changes in vessel density (VD) patterns induced by vascular endothelial growth factor inhibitors (anti-VEGF) in patients with diabetic macular edema (DME) using optical coherence tomography angiography (OCTA).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Prospective, interventional study. A total of 43 patients (63 eyes) were initially enrolled in the study. We performed swept source (SS) OCT and sectorial OCTA measurement to determine parafoveal VD at baseline and after six months of anti-VEGF treatment. In the locations with statistically significant differences in VD between baseline and month 6, we performed univariate and multivariate analyses to determine which, if any, of the baseline variables were associated with the observed changes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 34 patients (48 eyes) were included in the final analysis. Mean VD decreased from baseline to month 6 (from 45.2 (\u00b1\u20093.5) to 44.6 (\u00b1\u20093.2) % in the SCP and from 50 (\u00b1\u20093.3) to 49 (\u00b1\u20093.9) % in the DCP). The only significant changes in VD were observed in the nasal sector of the deep capillary plexus, with a decrease of 2.9% (<jats:italic>p<\/jats:italic>\u2009=\u20090.001). On univariate and multivariate analyses, the only variable significantly associated with changes in VD in the nasal sector after 6\u00a0months of treatment was baseline VD in the same sector.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Anti-VEGF therapy has a small impact on VD values over time. These variations observed after treatment seems to be related to changes over areas of vascular anomalies and displaced vessels adjacent to cystic areas, with no significant changes over ischemic areas. No correlation was observed between this trend and other clinical baseline features.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00592-024-02290-5","type":"journal-article","created":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T18:02:23Z","timestamp":1716832943000},"page":"1385-1392","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Changes in vessel density patterns assessed with OCTA in patients with diabetic macular edema treated with anti-VEGF therapy"],"prefix":"10.1007","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3304-3838","authenticated-orcid":false,"given":"Juan","family":"Santamar\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estefan\u00eda","family":"Cobos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Biarnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep Mar\u00eda","family":"Caminal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon","family":"Rodriguez-Leor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Morwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manel","family":"Garc\u00eda-Mendieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pere","family":"Garc\u00eda-Bru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Arias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,27]]},"reference":[{"issue":"10","key":"2290_CR1","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.oret.2019.04.027","volume":"3","author":"YT Hsieh","year":"2019","unstructured":"Hsieh YT, Alam MN, Le D et al (2019) OCT angiography biomarkers for predicting visual outcomes after ranibizumab treatment for diabetic macular edema. Ophthalmol Retina 3(10):826\u2013834. https:\/\/doi.org\/10.1016\/j.oret.2019.04.027","journal-title":"Ophthalmol Retina"},{"issue":"2","key":"2290_CR2","doi-asserted-by":"publisher","first-page":"CD013775","DOI":"10.1002\/14651858.CD013775.pub2","volume":"2","author":"J Perais","year":"2023","unstructured":"Perais J, Agarwal R, Evans JR et al (2023) Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy. Cochrane Database Syst Rev. 2(2):CD013775. https:\/\/doi.org\/10.1002\/14651858.CD013775.pub2","journal-title":"Cochrane Database Syst Rev."},{"issue":"1","key":"2290_CR3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.22608\/APO.201812","volume":"7","author":"C Or","year":"2018","unstructured":"Or C, Sabrosa AS, Sorour O, Arya M, Waheed N (2018) Use of OCTA, FA, and ultra-widefield imaging in quantifying retinal ischemia: a review. Asia Pac J Ophthalmol (Phila) 7(1):46\u201351. https:\/\/doi.org\/10.22608\/APO.201812","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"issue":"10","key":"2290_CR4","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1001\/jamaophthalmol.2013.4321","volume":"131","author":"M Adhi","year":"2013","unstructured":"Adhi M, Brewer E, Waheed NK, Duker JS (2013) Analysis of morphological features and vascular layers of choroid in diabetic retinopathy using spectral-domain optical coherence tomography. JAMA Ophthalmol 131(10):1267\u20131274. https:\/\/doi.org\/10.1001\/jamaophthalmol.2013.4321","journal-title":"JAMA Ophthalmol"},{"issue":"4","key":"2290_CR5","doi-asserted-by":"publisher","first-page":"487","DOI":"10.4103\/jovr.jovr_57_18","volume":"13","author":"J Khadamy","year":"2018","unstructured":"Khadamy J, AbriAghdam K, Falavarjani KG (2018) An update on optical coherence tomography angiography in diabetic retinopathy. J Ophthalmic Vis Res 13(4):487\u2013497. https:\/\/doi.org\/10.4103\/jovr.jovr_57_18","journal-title":"J Ophthalmic Vis Res"},{"issue":"9","key":"2290_CR6","doi-asserted-by":"publisher","first-page":"OCT362","DOI":"10.1167\/iovs.15-18904","volume":"57","author":"AY Kim","year":"2016","unstructured":"Kim AY, Chu Z, Shahidzadeh A, Wang RK, Puliafito CA, Kashani AH (2016) Quantifying microvascular density and morphology in diabetic retinopathy using spectral-domain optical coherence tomography angiography. Invest Ophthalmol Vis Sci. 57(9):OCT362\u2013OCT370. https:\/\/doi.org\/10.1167\/iovs.15-18904","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"2290_CR7","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.ajo.2020.04.024","volume":"217","author":"QS You","year":"2020","unstructured":"You QS, Wang J, Guo Y et al (2020) Optical coherence tomography angiography avascular area association with 1-year treatment requirement and disease progression in diabetic retinopathy. Am J Ophthalmol 217:268\u2013277. https:\/\/doi.org\/10.1016\/j.ajo.2020.04.024","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"2290_CR8","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/j.ophtha.2019.06.016","volume":"126","author":"Z Sun","year":"2019","unstructured":"Sun Z, Tang F, Wong R et al (2019) OCT angiography metrics predict progression of diabetic retinopathy and development of diabetic macular edema: a prospective study. Ophthalmology 126(12):1675\u20131684. https:\/\/doi.org\/10.1016\/j.ophtha.2019.06.016","journal-title":"Ophthalmology"},{"issue":"9","key":"2290_CR9","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/j.ophtha.2014.03.021","volume":"121","author":"PA Campochiaro","year":"2014","unstructured":"Campochiaro PA, Wykoff CC, Shapiro H, Rubio RG, Ehrlich JS (2014) Neutralization of vascular endothelial growth factor slows progression of retinal nonperfusion in patients with diabetic macular edema. Ophthalmology 121(9):1783\u20131789. https:\/\/doi.org\/10.1016\/j.ophtha.2014.03.021","journal-title":"Ophthalmology"},{"issue":"3","key":"2290_CR10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.oret.2017.07.003","volume":"2","author":"BG Moon","year":"2018","unstructured":"Moon BG, Um T, Lee J, Yoon YH (2018) Correlation between deep capillary plexus perfusion and long-term photoreceptor recovery after diabetic macular edema treatment. Ophthalmol Retina 2(3):235\u2013243. https:\/\/doi.org\/10.1016\/j.oret.2017.07.003","journal-title":"Ophthalmol Retina"},{"issue":"10","key":"2290_CR11","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1016\/j.ophtha.2018.04.002","volume":"125","author":"RK Reddy","year":"2018","unstructured":"Reddy RK, Pieramici DJ, Gune S et al (2018) Efficacy of ranibizumab in eyes with diabetic macular edema and macular nonperfusion in RIDE and RISE. Ophthalmology 125(10):1568\u20131574. https:\/\/doi.org\/10.1016\/j.ophtha.2018.04.002","journal-title":"Ophthalmology"},{"issue":"10","key":"2290_CR12","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1007\/s10792-019-01076-x","volume":"39","author":"OA Sorour","year":"2019","unstructured":"Sorour OA, Sabrosa AS, Yasin Alibhai A et al (2019) Optical coherence tomography angiography analysis of macular vessel density before and after anti-VEGF therapy in eyes with diabetic retinopathy. Int Ophthalmol 39(10):2361\u20132371. https:\/\/doi.org\/10.1007\/s10792-019-01076-x","journal-title":"Int Ophthalmol"},{"issue":"6","key":"2290_CR13","doi-asserted-by":"publisher","first-page":"343","DOI":"10.4274\/tjo.galenos.2020.81592","volume":"50","author":"KX Cheong","year":"2020","unstructured":"Cheong KX, Lee SY, Ang M, Teo KYC (2020) Vessel density changes on optical coherence tomography angiography after vascular endothelial growth factor inhibitor treatment for diabetic macular edema. Turk J Ophthalmol 50(6):343\u2013350. https:\/\/doi.org\/10.4274\/tjo.galenos.2020.81592","journal-title":"Turk J Ophthalmol"},{"key":"2290_CR14","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.3928\/15428877-20120712-05","volume":"43","author":"LS Leung","year":"2012","unstructured":"Leung LS, Silva RA, Blumenkranz MS, Flynn HW Jr, Sanislo SR (2012) Macular infarction following intravitreal bevacizumab for treatment of central retinal vein occlusion. Ophthalmic Surg Lasers Imaging 43:e73\u2013e79. https:\/\/doi.org\/10.3928\/15428877-20120712-05","journal-title":"Ophthalmic Surg Lasers Imaging"},{"issue":"3","key":"2290_CR15","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1136\/bjo.2009.160986","volume":"94","author":"M Shimura","year":"2010","unstructured":"Shimura M, Yasuda K (2010) Macular ischaemia after intravitreal bevacizumab injection in patients with central retinal vein occlusion and a history of diabetes and vascular disease. Br J Ophthalmol 94(3):381\u2013383. https:\/\/doi.org\/10.1136\/bjo.2009.160986","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"2290_CR16","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1136\/bjophthalmol-2019-314018","volume":"104","author":"K Ghasemi Falavarjani","year":"2020","unstructured":"Ghasemi Falavarjani K, Habibi A, Anvari P et al (2020) Effect of segmentation error correction on optical coherence tomography angiography measurements in healthy subjects and diabetic macular oedema. Br J Ophthalmol 104(2):162\u2013166. https:\/\/doi.org\/10.1136\/bjophthalmol-2019-314018","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"2290_CR17","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.3390\/ijms18061181","volume":"18","author":"L Toto","year":"2017","unstructured":"Toto L, D\u2019Aloisio R, Di Nicola M et al (2017) Qualitative and quantitative assessment of vascular changes in diabetic macular edema after dexamethasone implant using optical coherence tomography angiography. Int J Mol Sci. 18(6):1181. https:\/\/doi.org\/10.3390\/ijms18061181","journal-title":"Int J Mol Sci."},{"issue":"1","key":"2290_CR18","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/ceo.13648","volume":"48","author":"JI Fern\u00e1ndez-Vigo","year":"2020","unstructured":"Fern\u00e1ndez-Vigo JI, Kudsieh B, Shi H et al (2020) Normative database and determinants of macular vessel density measured by optical coherence tomography angiography. Clin Exp Ophthalmol 48(1):44\u201352. https:\/\/doi.org\/10.1111\/ceo.13648","journal-title":"Clin Exp Ophthalmol"},{"issue":"2","key":"2290_CR19","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1080\/09286586.2016.1259636","volume":"24","author":"GS Ying","year":"2017","unstructured":"Ying GS, Maguire MG, Glynn R, Rosner B (2017) Tutorial on biostatistics: linear regression analysis of continuous correlated eye data. Ophthalmic Epidemiol 24(2):130\u2013140. https:\/\/doi.org\/10.1080\/09286586.2016.1259636","journal-title":"Ophthalmic Epidemiol"},{"issue":"3","key":"2290_CR20","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1136\/bmj.h5527","volume":"277","author":"PM Bossuyt","year":"2015","unstructured":"Bossuyt PM, Reitsma JB, Bruns DE et al (2015) Research methods & reporting stard 2015: an updated list of essential items for reporting diagnostic accuracy studies. Radiology 277(3):826\u2013832. https:\/\/doi.org\/10.1136\/bmj.h5527","journal-title":"Radiology"},{"issue":"10","key":"2290_CR21","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1097\/IAE.0000000000001158","volume":"36","author":"RF Spaide","year":"2016","unstructured":"Spaide RF (2016) Retinal vascular Cystoid macular EDEMA: review and new theory. Retina 36(10):1823\u20131842. https:\/\/doi.org\/10.1097\/IAE.0000000000001158","journal-title":"Retina"},{"issue":"12","key":"2290_CR22","doi-asserted-by":"publisher","first-page":"3466","DOI":"10.1109\/JBHI.2020.3023308","volume":"24","author":"MS Sarabi","year":"2020","unstructured":"Sarabi MS, Khansari MM, Zhang J et al (2020) 3D retinal vessel density mapping with OCT-angiography. IEEE J Biomed Health Inform 24(12):3466\u20133479. https:\/\/doi.org\/10.1109\/JBHI.2020.3023308","journal-title":"IEEE J Biomed Health Inform"},{"key":"2290_CR23","doi-asserted-by":"publisher","first-page":"9496242","DOI":"10.1155\/2020\/9496242","volume":"2020","author":"L Toto","year":"2020","unstructured":"Toto L, Evangelista F, Viggiano P et al (2020) Changes in ocular blood flow after ranibizumab intravitreal injection for diabetic macular edema measured using laser speckle flowgraphy. Biomed Res Int 2020:9496242. https:\/\/doi.org\/10.1155\/2020\/9496242","journal-title":"Biomed Res Int"},{"issue":"2","key":"2290_CR24","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1167\/iovs.16-21115","volume":"58","author":"M Fukami","year":"2017","unstructured":"Fukami M, Iwase T, Yamamoto K, Kaneko H, Yasuda S, Terasaki H (2017) Changes in retinal microcirculation after intravitreal ranibizumab injection in eyes with macular edema secondary to branch retinal vein occlusion. Invest Ophthalmol Vis Sci 58(2):1246\u20131255. https:\/\/doi.org\/10.1167\/iovs.16-21115","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"2290_CR25","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s00417-018-3939-3","volume":"256","author":"M Okamoto","year":"2018","unstructured":"Okamoto M, Yamashita M, Ogata N (2018) Effects of intravitreal injection of ranibizumab on choroidal structure and blood flow in eyes with diabetic macular edema. Graefes Arch Clin Exp Ophthalmol 256(5):885\u2013892. https:\/\/doi.org\/10.1007\/s00417-018-3939-3","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"3","key":"2290_CR26","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.preteyeres.2008.02.002","volume":"27","author":"CJ Pournaras","year":"2008","unstructured":"Pournaras CJ, Rungger-Br\u00e4ndle E, Riva CE, Hardarson SH, Stefansson E (2008) Regulation of retinal blood flow in health and disease. Prog Retin Eye Res 27(3):284\u2013330. https:\/\/doi.org\/10.1016\/j.preteyeres.2008.02.002","journal-title":"Prog Retin Eye Res"},{"issue":"3","key":"2290_CR27","doi-asserted-by":"publisher","first-page":"544","DOI":"10.2337\/dc07-1528","volume":"31","author":"TT Nguyen","year":"2008","unstructured":"Nguyen TT, Wang JJ, Sharrett AR et al (2008) Relationship of retinal vascular caliber with diabetes and retinopathy: the Multi-ethnic study of atherosclerosis (MESA). Diabetes Care 31(3):544\u2013549. https:\/\/doi.org\/10.2337\/dc07-1528","journal-title":"Diabetes Care"},{"key":"2290_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2020.100884","volume":"81","author":"J Scharf","year":"2021","unstructured":"Scharf J, Freund KB, Sadda S, Sarraf D (2021) Paracentral acute middle maculopathy and the organization of the retinal capillary plexuses. Prog Retin Eye Res 81:100884. https:\/\/doi.org\/10.1016\/j.preteyeres.2020.100884","journal-title":"Prog Retin Eye Res"},{"issue":"Suppl 1","key":"2290_CR29","doi-asserted-by":"publisher","first-page":"S102","DOI":"10.1097\/IAE.0000000000001289","volume":"36","author":"V Man\u00e9","year":"2016","unstructured":"Man\u00e9 V, Dupas B, Gaudric A et al (2016) correlation between cystoid spaces in chronic diabetic macular edema and capillary nonperfusion detected by optical coherence tomography angiography. Retina 36(Suppl 1):S102\u2013S110. https:\/\/doi.org\/10.1097\/IAE.0000000000001289","journal-title":"Retina"},{"issue":"5","key":"2290_CR30","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1080\/09273948.2019.1704028","volume":"29","author":"A Dastiridou","year":"2021","unstructured":"Dastiridou A, Karathanou K, Riga P et al (2021) OCT angiography study of the macula in patients with diabetic macular edema treated with intravitreal aflibercept. Ocul Immunol Inflamm 29(5):926\u2013931. https:\/\/doi.org\/10.1080\/09273948.2019.1704028","journal-title":"Ocul Immunol Inflamm"},{"key":"2290_CR31","doi-asserted-by":"publisher","first-page":"247","DOI":"10.2147\/OPTH.S345947","volume":"16","author":"P Carnota-M\u00e9ndez","year":"2022","unstructured":"Carnota-M\u00e9ndez P, M\u00e9ndez-V\u00e1zquez C, P\u00e9rez-Gavela C (2022) OCT-angiography changes in patients with diabetic macular edema treated with intravitreal dexamethasone implant. Clin Ophthalmol. 16:247\u2013263. https:\/\/doi.org\/10.2147\/OPTH.S345947","journal-title":"Clin Ophthalmol."},{"issue":"8","key":"2290_CR32","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1007\/s00417-017-3692-z31","volume":"255","author":"M Sugimoto","year":"2017","unstructured":"Sugimoto M, Nunome T, Sakamoto R, Kobayashi M, Kondo M (2017) Effect of intravitreal ranibizumab on the ocular circulation of the untreated fellow eye. Graefes Arch Clin ExOphthalmol 255(8):1543\u20131550. https:\/\/doi.org\/10.1007\/s00417-017-3692-z31","journal-title":"Graefes Arch Clin ExOphthalmol"},{"issue":"7","key":"2290_CR33","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.oret.2017.11.004","volume":"2","author":"AH Kashani","year":"2018","unstructured":"Kashani AH, Green KM, Kwon J et al (2018) Suspended scattering particles in motion: a novel feature of OCT angiography in exudative maculopathies. Ophthalmol Retina 2(7):694\u2013702. https:\/\/doi.org\/10.1016\/j.oret.2017.11.004","journal-title":"Ophthalmol Retina"},{"issue":"6","key":"2290_CR34","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1097\/IAE.0000000000003016","volume":"41","author":"DS Maltsev","year":"2021","unstructured":"Maltsev DS, Kulikov AN, Kazak AA, Freund KB (2021) Suspended scattering particles in motion may influence optical coherence tomography angiography vessel density metrics in eyes with diabetic macular edema. Retina 41(6):1259\u20131264. https:\/\/doi.org\/10.1097\/IAE.0000000000003016","journal-title":"Retina"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-024-02290-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00592-024-02290-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-024-02290-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T06:02:48Z","timestamp":1730527368000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00592-024-02290-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,27]]},"references-count":34,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["2290"],"URL":"https:\/\/doi.org\/10.1007\/s00592-024-02290-5","relation":{},"ISSN":["1432-5233"],"issn-type":[{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,27]]},"assertion":[{"value":"10 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author(s) received no financial support for the research, authorship, and\/or publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This study involves human participants and was approved by ethics name ID, reference number EPA004\/20 of the Ethics Committee of drugs investigation at Hospital Universitari de Bellvitge. The research protocol adhered to the principles of the Declaration of Helsinki and was approved by the Clinical Research Ethics Committee at Bellvitge University Hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All patients signed an informed consent form before enrollment. All patient-related data were anonymized for this analysis. Written informed consent was obtained from participants to participate in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}